[Federal Register: October 20, 2005 (Volume 70, Number 202)]
[Notices]
[Page 61132-61133]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr20oc05-52]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Anesthetic and Life Support Drugs Advisory Committee; Notice of
Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). At least one
portion of the meeting will be closed to the public.
Name of Committee: Anesthetic and Life Support Drugs Advisory
Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on November 10, 2005, from
9 a.m. to 5 p.m.
Location: Food and Drug Administration, Center for Drug Evaluation
and Research Advisory Committee Conference Room, rm. 1066, 5630 Fishers
Lane, Rockville, MD.
Contact Person: Victoria Ferretti-Aceto, Center for Drug Evaluation
and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane,
(for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD
20857, 301-827-7001, FAX: 301-827-6776, e-mail: ferrettiv@cder.fda.gov,
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code
[[Page 61133]]
3014512529. Please call the Information Line for up-to-date information
on this meeting. When available, background materials for this meeting
will be posted one business day prior to the meeting on the FDA Web
site at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/ohrms/dockets/ac/acmenu.htm. (Click on the
year 2005 and scroll down to Anesthetic and Life Support Drugs Advisory
Committee).
Agenda: The meeting will be open to the public from 9 a.m. to 10
a.m., unless public participation does not last that long, from 10 a.m.
to 5 p.m., the meeting will be closed to permit discussion and review
of trade secret and/or confidential information.
Procedure: On November 10, 2005, from 9 a.m. to 10 a.m., the
meeting is open to the public. Interested persons may present data,
information, or views, orally or in writing, on issues pending before
the committee. Written submissions may be made to the contact person by
November 3, 2005. Oral presentations from the public will be scheduled
between approximately 9:15 a.m. to 10:15 a.m. Time allotted for each
presentation may be limited. Those desiring to make formal oral
presentations should notify the contact person before November 3, 2005,
and submit a brief statement of the general nature of the evidence or
arguments they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation.
Closed Presentation of Data: On November 10, 2005, from 10 a.m. to
5 p.m., the meeting will be closed to permit discussion and review of
trade secret and/or confidential information (5 U.S.C. 552b(c)(4)).
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Victoria Ferretti-
Aceto at least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: October 12, 2005.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. 05-20970 Filed 10-19-05; 8:45 am]
BILLING CODE 4160-01-S